Shimriet Zeidler

Dr. Shimriet Zeidler is a researcher in the Department of Clinical Genetics at Erasmus MC, a leading medical research institution in the Netherlands. Her work bridges clinical observation and genetic research, focusing on rare neurodevelopmental and metabolic disorders.

Her research interests include intellectual and developmental disabilities, neurodevelopmental disorders, epilepsy, and rare genetic syndromes such as BPTF haploinsufficiency and ATR-X syndrome. She also investigates metabolic defects like 5,10-methenyltetrahydrofolate synthetase deficiency. Her work contributes to understanding genotype-phenotype correlations in rare diseases.

The most recent publications highlight a strong trend in identifying novel phenotypes associated with rare genetic variants, particularly in neurogenetics and clinical genetics. Her studies often involve international collaborations and multi-center case analyses, contributing to the global understanding of rare disease manifestations.

Dr. Zeidler has not been publicly recognized with specific scientific awards in the provided text.

She has co-authored multiple significant publications in reputable journals such as Pediatric Neurology, American Journal of Human Genetics, and JIMD Reports, indicating active research and academic output. While no grants are explicitly mentioned, her involvement in multi-author studies suggests participation in funded research projects.

She is part of a collaborative research network within the Clinical Genetics department at Erasmus MC, working alongside experts in genetic diagnostics and metabolic diseases, contributing to a multidisciplinary approach in rare disease research.